These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14712427)

  • 1. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
    Yonemura K; Fukasawa H; Fujigaki Y; Hishida A
    Am J Kidney Dis; 2004 Jan; 43(1):53-60. PubMed ID: 14712427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.
    Yonemura K; Kimura M; Miyaji T; Hishida A
    Calcif Tissue Int; 2000 Feb; 66(2):123-8. PubMed ID: 10652960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S
    J Orthop Sci; 2000; 5(6):546-51. PubMed ID: 11180916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
    Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S
    Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide.
    Somekawa Y; Chigughi M; Harada M; Ishibashi T
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2700-4. PubMed ID: 10443663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of systemic vitamin k2 and vitamin d3 on gingival inflammation and alveolar bone in rats with experimentally induced periodontitis.
    Aral K; Alkan BA; Saraymen R; Yay A; Şen A; Önder GÖ
    J Periodontol; 2015 May; 86(5):666-73. PubMed ID: 25569194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Ichimura S
    Keio J Med; 2003 Sep; 52(3):147-50. PubMed ID: 14529146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone.
    Rianthavorn P; Pisutikul K; Deekajorndech T; Tepmongkol S; Suphapeetiporn K
    J Pediatr Endocrinol Metab; 2012; 25(3-4):307-12. PubMed ID: 22768661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
    Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
    Ann Intern Med; 1996 Dec; 125(12):961-8. PubMed ID: 8967706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of vitamin D3 on inhibitory effect of vitamin K2 on bone loss in ovariectomized rats].
    Hara K; Akiyama Y; Tomiuga T; Kobayashi M; Nakamura T; Tajima T
    Nihon Yakurigaku Zasshi; 1994 Aug; 104(2):101-9. PubMed ID: 7927067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy.
    Iwamoto I; Kosha S; Noguchi S; Murakami M; Fujino T; Douchi T; Nagata Y
    Maturitas; 1999 Jan; 31(2):161-4. PubMed ID: 10227010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
    Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
    J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study.
    Solmaz I; Ozdemir MA; Unal E; Abdurrezzak U; Muhtaroglu S; Karakukcu M
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):441-447. PubMed ID: 33639045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids.
    Wissing KM; Broeders N; Moreno-Reyes R; Gervy C; Stallenberg B; Abramowicz D
    Transplantation; 2005 Jan; 79(1):108-15. PubMed ID: 15714177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.
    Shiomi S; Nishiguchi S; Kubo S; Tamori A; Habu D; Takeda T; Ochi H
    Am J Gastroenterol; 2002 Apr; 97(4):978-81. PubMed ID: 12003435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.